LEXX (Lexaria Bioscience Corp. Common Stock) Stock Analysis - Politician Trades

Lexaria Bioscience Corp. Common Stock (LEXX) is a publicly traded Healthcare sector company. As of May 19, 2026, LEXX trades at $0.57 with a market cap of $14.68M and a P/E ratio of 0.00. LEXX moved -0.07% today. Year to date, LEXX is -14.36%; over the trailing twelve months it is -44.54%. Its 52-week range spans $0.46 to $3.39. Rallies surfaces LEXX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Which politicians traded LEXX stock?

Rallies tracks politician and congressional stock disclosures for LEXX, including purchases, sales, transaction dates, owners, and reported trade amounts when available.

LEXX Key Metrics

Key financial metrics for LEXX
MetricValue
Price$0.57
Market Cap$14.68M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$3.39
52-Week Low$0.46
Volume38.50K
Avg Volume0
Revenue (TTM)$705.92K
Net Income$-11.91M
Gross Margin99.61%

Latest LEXX News

Recent LEXX Insider Trades

  • BUNKA CHRISTOPHER bought 11.90K (~$10.87K) on Jul 30, 2025.
  • BUNKA CHRISTOPHER bought 15.60K (~$14.38K) on Jul 29, 2025.
  • McKechnie William Edward bought 5.00K (~$4.53K) on Jul 29, 2025.

LEXX Analyst Consensus

LEXX analyst coverage data. Average price target: $0.00.

Common questions about LEXX

Which politicians traded LEXX stock?
Rallies tracks politician and congressional stock disclosures for LEXX, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Does Rallies track congressional trades in LEXX?
Yes. Rallies tracks politician and congressional stock disclosures for LEXX, including reported purchases, sales, dates, owners, and trade amounts when available.
Is LEXX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for LEXX. It does not provide personalized investment advice.
LEXX

LEXX